OrthoPediatrics Corp. (KIDS)

Market Cap	403.70M -33.3%
Revenue (ttm)	236.35M +15.4%
Net Income	-39.65M
EPS	-1.69
Shares Out	25.28M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	147,115
Open	16.06
Previous Close	15.94
Day's Range	15.63 - 16.27
52-Week Range	14.91 - 23.70
Beta	1.16
Analysts	Strong Buy
Price Target	24.67 (+54.48%)
Earnings Date	May 6, 2026

About KIDS

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruct...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 12, 2017
• Employees: 602
• Stock Exchange: NASDAQ
• Ticker Symbol: KIDS
• Website: https://www.orthopediatrics.com

Financial Performance

In 2025, OrthoPediatrics's revenue was $236.35 million, an increase of 15.45% compared to the previous year's $204.73 million. Losses were -$39.65 million, 4.83% more than in 2024.

Analyst Summary

According to 9 analysts, the average rating for KIDS stock is "Strong Buy." The 12-month stock price target is $24.67, which is an increase of 54.48% from the latest price.

Price Target

$24.67

(54.48% upside)

Analyst Consensus: Strong Buy